Order Permitting Emergency Dispensing of Oral Formulations of Ciprofloxacin and Waiver of CGMP

U.S. Food and Drug Administration. (2016). Order Permitting Emergency Dispensing of Oral Formulations of Ciprofloxacin and Waiver of CGMP (Current Good Manufacturing Practice) Requirements During an Anthrax Emergency.
This order allows public health emergency stakeholders to execute plans for “emergency dispensing of eligible ciprofloxacin products without individual prescriptions in the future if they reasonably believe there is a need to do so because of their constituents’ known, suspected, or likely imminent exposure to B. anthracis.”
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.